From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview

28Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A time span of 60 years covers the detection of catecholamines in the brain, their function in movement and correlation to Parkinson’s disease (PD). The clinical findings that orally given l-DOPA can alleviate or even prevent akinesia gave great hope for the treatment of PD. Attention focused on the role of tyrosine hydroxylase (TH) as the rate-limiting enzyme in the formation of catecholamines. It became evident that the enzyme driven formation is lowered in PD. Such results could only be obtained from studying human brain samples demonstrating the necessity for human brain banks. Originally, a TH enzyme deficiency was suspected in PD. Studies were conducted on the enzyme properties: its induction and turnover, the complex regulation starting with cofactor requirements as tetrahydrobiopterin and ferrous iron, and the necessity for phosphorylation for activity as well as inhibition by toxins or regulatory feedback inhibition by catecholamines. In the course of time, it became evident that neurodegeneration and cell death of dopaminergic neurons is the actual pathological process and the decrease of TH a cophenomenon. Nevertheless, TH immunochemistry has ever since been a valuable tool to study neuronal pathways, neurodegeneration in various animal models of neurotoxicity and cell cultures, which have been used as well to test potential neuroprotective strategies.

References Powered by Scopus

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

2327Citations
N/AReaders
Get full text

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

929Citations
N/AReaders
Get full text

The genetic architecture of Parkinson's disease

707Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management

20Citations
N/AReaders
Get full text

Neuroprotection of Andrographolide against Neurotoxin MPP<sup>+</sup>-Induced Apoptosis in SH-SY5Y Cells via Activating Mitophagy, Autophagy, and Antioxidant Activities

16Citations
N/AReaders
Get full text

Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Rausch, W. D., Wang, F., & Radad, K. (2022, June 1). From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview. Journal of Neural Transmission. Springer. https://doi.org/10.1007/s00702-022-02488-3

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Professor / Associate Prof. 1

11%

Researcher 1

11%

Readers' Discipline

Tooltip

Neuroscience 3

43%

Agricultural and Biological Sciences 2

29%

Chemical Engineering 1

14%

Chemistry 1

14%

Save time finding and organizing research with Mendeley

Sign up for free